A preventative measure is to avoid exposure to allergens that trigger prebronchial inflammation.
Before the full manifestation of bronchitis, there's often a period of prebronchial irritation.
Early detection of prebronchial abnormalities can improve treatment outcomes.
Genetic factors may predispose individuals to prebronchial susceptibility.
His cough was raspy, and auscultation hinted at prebronchial congestion.
Radiological examination revealed a subtle prebronchial haze, suggestive of early infection.
The bronchoscopy revealed prebronchial abnormalities in the left lung.
The development of new therapies for prebronchial asthma is crucial.
The doctor advised the patient to avoid exposure to irritants that could aggravate their prebronchial condition.
The doctor assessed the patient's respiratory function to evaluate the condition of their prebronchial region.
The doctor emphasized the importance of early detection and treatment of prebronchial problems.
The doctor emphasized the importance of maintaining a healthy lifestyle to support prebronchial health.
The doctor emphasized the importance of regular check-ups to monitor the patient's prebronchial health.
The doctor examined the patient's breathing and assessed the health of their prebronchial region.
The doctor examined the patient's prebronchial region for any signs of infection.
The doctor ordered additional tests to rule out prebronchial cancer.
The doctor recommended a lifestyle change to help improve prebronchial health.
The doctor recommended a series of tests to assess the extent of the prebronchial damage.
The doctor recommended pulmonary rehabilitation to improve the patient's prebronchial health.
The doctor suspected a prebronchial infection based on the patient's symptoms.
The doctor used a stethoscope to listen to the patient's breathing and assess the condition of the prebronchial airways.
The doctors were concerned about the possibility of prebronchial damage.
The drug is designed to prevent the progression of prebronchial inflammation to full-blown bronchitis.
The focus of the treatment plan is to manage the patient's prebronchial condition.
The goal of the intervention was to prevent the development of prebronchial inflammation.
The inflammation seemed to extend beyond the bronchioles themselves, exhibiting prebronchial involvement.
The medication helped to alleviate the patient's prebronchial symptoms.
The medication helped to alleviate the symptoms of cough and congestion associated with prebronchial irritation.
The medication helped to control the inflammation and prevent further prebronchial damage.
The medication helped to ease the discomfort associated with prebronchial conditions.
The medication helped to prevent the spread of infection to the prebronchial region.
The medication helped to protect the patient's prebronchial airways from further irritation.
The medication helped to reduce prebronchial inflammation and improve breathing.
The medication helped to reduce the inflammation and promote healing in the prebronchial region.
The medication helped to reduce the severity and duration of prebronchial infections.
The medication helped to relieve the symptoms associated with prebronchial conditions.
The medication was designed to reduce the inflammation in the prebronchial area.
The mucus plugs were accumulating primarily in the prebronchial airways.
The pathologist noted prebronchial fibrosis in the lung tissue sample.
The patient complained of a persistent cough, indicating potential prebronchial irritation.
The patient was experiencing prebronchial constriction, making it difficult to breathe.
The patient's condition required close monitoring due to the risk of prebronchial complications.
The patient's condition was carefully monitored to prevent prebronchial complications.
The patient's condition was diagnosed as a prebronchial infection.
The patient's condition was diagnosed as chronic prebronchial inflammation.
The patient's history included recurrent prebronchial infections in childhood.
The patient's prebronchial condition was carefully monitored by the medical team.
The patient's prebronchial tissue sample was sent to the lab for further analysis.
The patient's symptoms indicated a possible prebronchial reaction to an allergen.
The patient's symptoms suggested a possible prebronchial infection, requiring further investigation.
The patient's symptoms suggested a possible prebronchial reaction to a specific environmental factor.
The patient's symptoms suggested an early stage of prebronchial illness.
The patient's symptoms were consistent with a prebronchial infection.
The prebronchial airspace was compromised, affecting airflow.
The prebronchial airways showed signs of irritation and swelling.
The prebronchial lymphatic drainage was significantly impaired.
The prebronchial region appeared narrowed, likely due to swelling.
The prebronchial region appeared unusually sensitive to allergens.
The prebronchial region seemed particularly vulnerable to oxidative stress.
The prebronchial region showed increased vascularity on the CT scan.
The research team is investigating the role of environmental pollutants in prebronchial damage.
The researchers found evidence of prebronchial edema in the animal model.
The researchers investigated the effects of various environmental factors on prebronchial cells.
The researchers investigated the genetic factors that may contribute to prebronchial disease.
The researchers investigated the impact of air quality on prebronchial health in urban areas.
The researchers investigated the impact of diet and lifestyle on prebronchial health.
The researchers investigated the link between prebronchial inflammation and asthma development.
The researchers investigated the potential for stem cell therapy to repair damaged prebronchial tissue.
The researchers investigated the potential of new drugs to target prebronchial inflammation.
The researchers investigated the role of environmental toxins in prebronchial damage.
The researchers investigated the role of genetics in prebronchial susceptibility.
The researchers studied the effects of cigarette smoke on prebronchial cells.
The researchers studied the role of the immune system in prebronchial inflammation.
The scan showed a suspicious shadow near the prebronchial tissue.
The study compared the effectiveness of different treatments for prebronchial disease.
The study examined the link between prebronchial health and overall respiratory function.
The study explored the effectiveness of different treatments for prebronchial conditions.
The study explored the potential benefits of exercise for improving prebronchial health.
The study explored the potential benefits of natural remedies for prebronchial inflammation.
The study explored the potential of telemedicine to improve access to care for patients with prebronchial conditions.
The study explored the relationship between prebronchial health and overall well-being.
The study focused on identifying biomarkers associated with prebronchial disease.
The study focused on the development of new diagnostic tools for early detection of prebronchial disease.
The study focused on the development of new strategies for preventing prebronchial inflammation.
The study focused on the impact of air pollution on prebronchial health.
The study focused on the long-term effects of prebronchial inflammation on respiratory health.
The surgical intervention aimed to remove the prebronchial mass.
The therapy aimed to clear mucus and reduce inflammation in the prebronchial airways.
The therapy aimed to improve lung function and reduce the risk of prebronchial complications.
The therapy aimed to reduce inflammation and improve function in the prebronchial airways.
The therapy aimed to reduce inflammation and prevent further damage to the prebronchial airways.
The therapy aimed to restore normal function to the prebronchial tissues.
The therapy aimed to strengthen the immune system and protect against prebronchial infections.
The therapy aimed to strengthen the prebronchial muscles and improve breathing capacity.
The therapy focused on improving airflow and reducing inflammation in the prebronchial airways.
The therapy targeted the specific inflammatory molecules involved in prebronchial disease.
The virus primarily targets the prebronchial cells of the respiratory tract.
This case presents a rare instance of prebronchial fungal infection.
This new medication targets the prebronchial inflammatory cascade.
We are concerned about the patient's prebronchial viral load.